王泽琴,米秀娟,陶文强,舒建中,李陈渝,赵玉华,龚廷亮,罗文澜,唐军

• 1:贵州中医药大学
• 2:重庆市中医院

摘要(Abstract)：

目的观察刺血醒脑法对急性脑梗死患者血清白细胞介素-1β(IL-1β)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)的影响并探讨其作用机制。方法患者60例随机分为两组,对照组给予指南规范化的西医治疗与西医康复治疗,观察组在对照组治疗基础上加用刺血醒脑法。观察两组患者治疗前后血清IL-1β、hs-CRP、TNF-α水平,并进行美国国立卫生研究院卒中量表(NIHSS)评价临床疗效。结果治疗后两组ACI患者血清IL-1β、hs-CRP、TNF-α水平均低于治疗前(P <0.05),且观察组低于对照组(P <0.05);治疗后两组较治疗前NIHSS评分均下降(P <0.05),且观察组低于对照组(P <0.05);观察组临床总有效率为86.00%,显著优于对照组的76.00%(P <0.05)。结论刺血醒脑法可以降低急性脑梗死患者血清IL-1β、hs-CRP、TNF-α水平,抑制血管炎性反应。

关键词(KeyWords)： 急性脑梗死;刺血醒脑法;针刺

Abstract:

Keywords:

基金项目(Foundation): 重庆市社会事业与民生保障科技创新专项项目(重点)子课题(csts2016shms-zd10001-13)

作者(Author): 王泽琴,米秀娟,陶文强,舒建中,李陈渝,赵玉华,龚廷亮,罗文澜,唐军

参考文献(References)：

• [1]Anrather J,Iadecola C.Inflammation and stroke:an overview[J].Neurotherapeutics,2016,13(4):661-670.
• [2]Fu Y,Liu Q,Anrather J,et al.Immune interventions in stroke[J].Nat Rev Neurol,2015,11(9):524-535.
• [3]穆艳云，夏有兵，程洁，等.我国刺血疗法研究现状及思考[J].南京中医药大学学报，2011,27(6):594-597.
• [4]中华神经科学会，中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志，1996,29(6):397.
• [5]中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志，2015,48(4):246-257.
• [6]Tong DC,Yenari MA,Albers GW,et al.Correlation of perfusion-and diffusion-weighted MRI with NIHSS score in acute(<6.5 hour)ischemic stroke[J].Neurology,1998,50(4):864-870.
• [7]王宏盛，陈正楼，胥敏，等.高压氧联合神经节苷脂辅助治疗高血压脑出血术后效果分析[J].中国实用神经疾病杂志，2013,16(20):25-26.
• [8]Chamorro A,Meisel A,Planas AM,et al.The immunology of acute stroke[J].Nat Rev Neurol,2012,8(7):401-410.
• [9]Ridker PM.Interleukin-1 inhibition and ischaemic stroke:has the time for a major outcomes trial arrived[J].Eur Heart J,2018,39(38):3518-3520.
• [10]Spulber S,Schultzberg M.Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1[J].Prog Neurobiol,2010,90(2):256-262.
• [11]Pan W,Kastin AJ.Tumor necrosis factor and stroke:role of the blood-brain barrier[J].Prog Neurobiol,2007,83(6):363-374.
• [12]Castillo J,Moro MA,Blanco M,et al.The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke[J].Ann Neurol,2003,54(6):811-819.
• [13]Montaner J,Chacon P,Krupinski J,et al.Simvastatin in the acute phase of ischemic stroke:a safety and efficacy pilot trial[J].Eur J Neurol,2008,15(1):82-90.
• [14]Mody P,Joshi PH,Khera A,et al.Beyond coronary calcification,family history,and C-reactive protein:cholesterol efflux capacity and cardiovascular risk prediction[J].J Am Coll Cardiol,2016,67(21):2480-2487.
• [15]林晓东，赵丽，王学敏，等.急性脑梗死与超敏C反应蛋白的关系[J].中华脑血管病杂志，2009,3(1):17-19.
• [16]Oh SH,Choi C,Noh JE,et al.Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model[J].Exp Mol Med,2018,50(4):22.
• [17]Tong Y,Wang Z,Geng Y,et al.The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke:analysis in two Chinese populations[J].Biochem Biophys Res Commun,2010,391(1):481-485.
• [18]Idicula TT,Brogger J,Naess H,et al.Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality:the'Bergen stroke study[J].BMCNeurol,2009(9):18.2019-06-20